SUBSCRIBE
SUBSCRIBE

Amylyx Pharmaceuticals

NEWS
Business
BioSpace Movers & Shakers, Jan. 15
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers and Shakers.
January 14, 2021
 · 
5 min read
 · 
Alex Keown
Load More
JOBS
IN THE PRESS
Policy
Amylyx Pharmaceuticals Completes Negotiation Process and Signs Letter of Intent with the pCPA for ALBRIOZA™ for the Treatment of ALS
June 15, 2023
 · 
7 min read
Genetown
Amylyx Pharmaceuticals to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
June 6, 2023
 · 
1 min read
Genetown
Amylyx Pharmaceuticals Provides Update on Ongoing Regulatory Review of AMX0035 for the Treatment of ALS in the European Union
May 30, 2023
 · 
8 min read
Business
Amylyx Pharmaceuticals Reports First Quarter 2023 Financial Results
May 11, 2023
 · 
13 min read
Business
Amylyx Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023
May 5, 2023
 · 
1 min read
Business
Amylyx Pharmaceuticals Appoints Masako Nakamura to General Manager and Head of International Markets - Asia Pacific and Latin America
April 20, 2023
 · 
7 min read
Drug Development
Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 2 Study of AMX0035 for the Treatment of Wolfram Syndrome
April 13, 2023
 · 
6 min read
Genetown
Amylyx Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
 · 
1 min read
Business
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
March 13, 2023
 · 
14 min read
Genetown
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
March 8, 2023
 · 
1 min read
Load More